Skip to content

Feasibility Study of a Guided Imagery Therapy Mobile Application for Functional Abdominal Pain Disorders in Children

Open-Labelled Feasibility Study of a Guided Imagery Therapy Mobile Application for Functional Abdominal Pain Disorders in Children

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07222943
Enrollment
63
Registered
2025-10-30
Start date
2026-09-08
Completion date
2027-04-30
Last updated
2026-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Pain/ Discomfort, Functional Abdominal Pain Disorders, Functional Dyspepsia, Functional Gastrointestinal Disorders (FGIDs), Gastrointestinal and Digestive Disorder, Irritable Bowel Syndrome (IBS), Pain

Keywords

abdominal pain, irritable bowel syndrome

Brief summary

Chronic abdominal pain is common among children, and the majority of cases are attributed to functional abdominal pain disorders. One approach to treating these disorders is by using psychological therapies. This clinical trial aims to see how well pre-recorded guided imagery therapy sessions help children's abdominal pain when delivered via a mobile application (app) on a smartphone or tablet. Participants will complete a baseline abdominal pain and stooling diary to determine eligibility, as well as other surveys. Eligible participants will be given access to the guided imagery therapy mobile application. This intervention asks participants to listen to a 10- to 15-minute GIT session 5 out of 7 days per week for 8 weeks, in addition to their usual care for their abdominal pain. Then, participants will complete another abdominal pain and stooling diary, along with other psychometric surveys, at the end of this intervention period. Participants will also collect another diary and surveys 3 months post-treatment.

Detailed description

After fully disclosing the study design, intervention options, randomization scheme, and potential side effects of the interventions, caregivers and their children will document their respective informed consent and assent electronically. REDCap is a secure web application designed for surveys and databases. All data captured through REDCap will be encrypted and transmitted securely to HIPAA-compliant institutional servers for storage. Participants and their caregivers will complete the following surveys at baseline, immediately post-therapy (8 weeks after baseline), and 3 months post-treatment through REDCap: * 2-week Abdominal Pain and Stooling Diary * Children's Somatic Symptoms Inventory (child self-report and parent proxy-report) * Pain Catastrophizing Scale - Child Version * Pain Catastrophizing Scale - Parent Version * Pediatric Quality of Life Inventory 4.0 Generic Core (child self-report and parent proxy-report) * Behavior Assessment System for Children 3rd Ed (child self-report and parent proxy-report)

Interventions

Participants will be asked to listen to a pre-recorded, 10 to 15 minute guided imagery therapy (GIT) sessions via mobile application 5 out of 7 days per week for 8 weeks in addition to their usual care for their abdominal pain.

Sponsors

Baylor College of Medicine
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Qualified participants will be given access to the mobile app intervention for eight weeks. At the end of the eight weeks, outcome measures will be reassessed through an abdominal pain and stooling diary and other surveys. we will also assess these same outcomes 3 months -post-treatment.

Eligibility

Sex/Gender
ALL
Age
7 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Texas Children's Pediatrics patients 7 to 12 years old at enrollment * A Rome IV Functional Abdominal Pain Disorder as defined by a 2-week abdominal pain and stooling diary * Both children and their primary caregivers must be able to read and communicate in English proficiently to understand the intervention's audio therapy sessions and psychometric instruments.

Exclusion criteria

* Previous abdominal surgeries * Co-morbid conditions associated with abdominal pain (e.g., cystic fibrosis) * Autism * Significant development delay * Psychosis * Prior experience with cognitive behavioral therapy or guided imagery therapy to treat chronic abdominal pain * Alarm symptoms that warrant further medical evaluation (e.g., blood in stool)

Design outcomes

Primary

MeasureTime frameDescription
Abdominal Pain IntensityBaseline and Post-intervention (immediately after 8-week intervention)Average daily abdominal pain severity measured on a 0-10 (10 is most severe) ordinal scale from a self-report 2-week abdominal pain diary

Secondary

MeasureTime frameDescription
Abdominal Pain FrequencyBaseline and Post-intervention (immediately after 8-week intervention)Average number of abdominal pain episodes per day from a self-report 2-week abdominal pain diary
AnxietyBaseline and Post-intervention (immediately after 8-week intervention)Patient-Reported Outcomes Measurement Information System (PROMIS), Pediatric Anxiety Short Form 8a, t score ranges from approximately 36 to 83, higher scores are worse
DepressionBaseline and Post-intervention (immediately after 8-week intervention)Patient-Reported Outcomes Measurement Information System (PROMIS), Pediatric Depressive Symptoms Short Form 8a, t score ranges from approximately from 38-82, higher scores are worse
SomatizationBaseline and Post-intervention (immediately after 8-week intervention)Children's Somatic Symptoms Inventory child self-report, raw score ranges from 0 to 96, higher scores are worse
Pain Catastrophizing ThoughtsBaseline and Post-intervention (immediately after 8-week intervention)Pain Catastrophizing Scale - Child Version, raw score ranges from 0 to 52, higher scores are worse
Health-Related Quality of LifeBaseline and Post-intervention (immediately after 8-week intervention)Pediatric Quality of Life Inventory Generic Core Scales 4.0 child self-report, raw score ranges from 0 to 100, higher scores are better

Countries

United States

Contacts

CONTACTHollier, MD
GITgoStudy@bcm.edu832-824-3814

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 18, 2026